BUKOVINIAN STATE MEDICAL UNIVERSITY, CHERNIVTSI, UKRAINE.
Pol Merkur Lekarski. 2023;51(3):234-238. doi: 10.36740/Merkur202303108.
Aim: To examine the expression Nlrp3-inflammasome in the blood of women with endometriosis-associated infertility using assisted reproductive technologies with included probiotic and estimate a new approach with included probiotic for preparation to assisted reproductive technologies.
Materials and methods: For the purpose of the research we examined 30 infertile women. Control group consisted of 10 women with tubal infertility due to an inflammatory process in the anamnesis, in whom, as a result of a complex clinical and laboratory examination, no other diseases were detected and in terms of their health they could be equated with practically healthy women (age from 21 to 42 years, the average age was 29.75 years) and who did not take probiotic. The main group consists from 20 women with external genital endometriosis were included in assisted reproductive technologies. Patients from main group took probiotic produced by Unic Biotech Ltd, India. 1 tablet twice a day with 10×109 Lactobacillus during 1 month in complex preparation (treatment) before assisted reproductive technologies. The indices of Nlrp3 - Inflammasome determined before and after preparation. The study was performer in Bukovinian State Medical University and Centre of Reproductive Medicine. To analyze the expression of the NLPP3-inflammasome gene and determine the relative normalized expression of NLPP3 mRNA, we used the polymerase chain reaction with reverse transcription in real time (RT-PCR). The object for molecular genetic studies by the RT-PCR method was the fraction of mononuclear cells isolated from the whole blood of patients with endometriosis. The value of p (authenticity difference) was determined by Student's table-Fischer. Differences between contrasting averages were considered significant at p <0.05.
Results: Analized the results of our research stated that in main group expression of Nlrp-3 inflammasome was 24,43, which is significantly higher than after preparation (0,70 accordingly). In control group expression of Nlrp3-inflammasome was 0,54. Expression of Nlrp-3 inflammasome increased in patients before preparation more than 34 times compare with patients after preparation accordingly.
Conclusions: consequently, after using probiotic, the increased level of Nlrp3-inflammasome sharply decreases, indicating the effectiveness and the possibility of use in the programme for assisted reproductive technologies preparation.
研究子宫内膜异位症相关不孕患者采用辅助生殖技术时血液中 Nlrp3 炎性小体的表达,并评估一种包含益生菌的新方法在辅助生殖技术中的应用。
为了进行这项研究,我们检查了 30 名不孕妇女。对照组由 10 名因既往炎症过程而导致输卵管性不孕的妇女组成,在这些妇女中,通过综合临床和实验室检查,未发现其他疾病,并且在健康方面可以与健康妇女相媲美(年龄 21 至 42 岁,平均年龄为 29.75 岁),且未服用益生菌。主要组由 20 名患有外阴子宫内膜异位症的妇女组成,这些妇女被纳入辅助生殖技术中。主要组的患者在辅助生殖技术前接受印度 Unic Biotech Ltd 生产的益生菌治疗。在辅助生殖技术前 1 个月,每天服用 2 次 1 片,剂量为 10×109 个乳酸杆菌。在准备(治疗)前后测定 Nlrp3-炎性小体的指数。该研究在布科维纳州立医科大学和生殖医学中心进行。为了分析 NLPP3-炎性小体基因的表达并确定 NLPP3 mRNA 的相对正常表达,我们使用实时聚合酶链反应(RT-PCR)进行研究。通过 RT-PCR 方法进行分子遗传学研究的对象是从子宫内膜异位症患者的全血中分离的单核细胞部分。通过学生 t 检验表-Fischer 确定 p 值(真实性差异)。当 p<0.05 时,认为对比平均值之间的差异具有统计学意义。
分析我们的研究结果表明,在主要组中,Nlrp-3 炎性小体的表达为 24.43,明显高于准备后(相应为 0.70)。在对照组中,Nlrp3-炎性小体的表达为 0.54。与准备后相比,患者在准备前的 Nlrp-3 炎性小体表达增加了 34 多倍。
因此,在使用益生菌后,Nlrp3-炎性小体的升高水平急剧下降,表明该方法有效,并且可能用于辅助生殖技术准备方案中。